IGC Pharma (IGC) EBITDA Margin Growth (1y) (2011 - 2025)
IGC Pharma (IGC) EBITDA Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-54,296.00 |
| Jun 30, 2025 |
38,695.00 |
| Mar 31, 2025 |
61,608.00 |
| Dec 31, 2024 |
201,221.00 |
| Sep 30, 2024 |
44,353.00 |
| Jun 30, 2024 |
-50,312.00 |
| Mar 31, 2024 |
142,572.00 |
| Dec 31, 2023 |
-203,510.00 |
| Sep 30, 2023 |
43,509.00 |
| Jun 30, 2023 |
104,473.00 |
| Mar 31, 2023 |
309,535.00 |
| Dec 31, 2022 |
92,675.00 |
| Sep 30, 2022 |
642,242.00 |
| Jun 30, 2022 |
101,679.00 |
| Mar 31, 2022 |
-179,836.00 |
| Dec 31, 2021 |
49,135.00 |
| Sep 30, 2021 |
-650,943.00 |
| Jun 30, 2021 |
-210,157.00 |
| Mar 31, 2021 |
808,621.00 |
| Dec 31, 2020 |
-182,663.00 |
